Two Sigma Securities’s Matinas BioPharma MTNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-12,560
Closed -$23.7K 1828
2025
Q3
$23.7K Buy
+12,560
New +$18.1K ﹤0.01% 1109
2025
Q2
Sell
-20,974
Closed -$10.9K 1875
2025
Q1
$10.9K Buy
+20,974
New +$12.4K ﹤0.01% 1219
2024
Q1
Sell
-382
Closed -$4.13K 3399
2023
Q4
$4.13K Buy
+382
New +$4.31K ﹤0.01% 2899
2022
Q1
Sell
-732
Closed -$37K 2364
2021
Q4
$37K Sell
732
-716
-49% -$38.3K ﹤0.01% 1321
2021
Q3
$94K Buy
+1,448
New +$62.5K ﹤0.01% 1326
2021
Q2
Sell
-1,639
Closed -$86K 1632
2021
Q1
$86K Buy
+1,639
New +$110K ﹤0.01% 705
2020
Q2
Sell
-217
Closed -$6K 1595
2020
Q1
$6K Buy
+217
New +$13.1K ﹤0.01% 1257
2018
Q1
Sell
-303
Closed -$18K 2851
2017
Q4
$18K Buy
303
+53
+21% +$3.41K ﹤0.01% 1635
2017
Q3
$16K Sell
250
-165
-40% -$11K ﹤0.01% 842
2017
Q2
$35K Buy
+415
New +$55.7K 0.01% 740

Other funds holding MTNB

Two Sigma Securities's MTNB Position: Q4 2025 in Review

Two Sigma Securities sold out of Matinas BioPharma (MTNB) in Q4 2025, closing a stake of 12,560 shares — an estimated $23.7K sold.

Two Sigma Securities first reported a position in MTNB in Q2 2017 and held it in 10 quarters. The position peaked at $94K in Q3 2021. 30 funds tracked by Wall St. Rank hold MTNB as of Q4 2025.

  • Two Sigma Securities reported no remaining Matinas BioPharma position as of Q4 2025 after selling out during the quarter.
  • Two Sigma Securities sold 12,560 Matinas BioPharma shares in Q4 2025, an estimated $23.7K.
  • Two Sigma Securities first reported a position in Matinas BioPharma in Q2 2017 and held it in 10 quarters.
  • Two Sigma Securities's Matinas BioPharma position peaked at $94K in Q3 2021.
  • 30 funds tracked by Wall St. Rank held Matinas BioPharma as of Q4 2025.

Based on Two Sigma Securities's 13F filing for Q4 2025, filed 17 Feb 2026.